The National Trial Lawyers
  • Home
    • Meet Our Team
    • Contact Us
    • Mission & Goals
    • FAQ
  • Webinars
  • News
  • Membership Directory
    • Top 100 Map – Civil Plaintiff
    • Top 100 Map – Criminal Defense
    • Top 40 Under 40 Map – Civil Plaintiff
    • Top 40 Under 40 Map – Criminal Defense
  • Top 100
    • Civil Plaintiff Officers / Executive Committee
    • Criminal Defense Officers / Executive Committee
    • Benefits
    • About
    • Top 100 Presidents Message
    • Diplomat
    • Membership Renewal
    • Member Profile Updates
    • Top 100 Badge
  • Top 40
    • Civil Plaintiff Officers / Executive Committee
    • Criminal Defense Officers / Executive Committee
    • Top 40 Under 40 Trial Academy Bootcamp
    • Benefits
    • About
    • Top 40 Presidents Message
    • Membership Renewal
    • Member Profile Updates
    • Top 40 Badge
  • Specialty Assoc
    • About
    • Shop
    • Officers
    • Membership Renewal
    • Member Profile Updates
  • Nominate
    • Top 100
    • Top 40
    • Specialty Association
    • Trial Lawyer Hall of Fame
    • Trial Lawyer of the Year
    • Trial Team of the Year
    • America’s Most Influential Trial Lawyer
    • America’s Most Influential Law Firm
    • Lifetime Achievement Award
  • Shop
  • Magazine
    • A-List
  • Education and Networking Agenda
    • Trial Lawyers Summit
    • Top 40 Under 40 Trial Academy Boot Camp
    • Mass Torts Made Perfect
    • The Lanier Trial Academy Master Class 6.0
    • The Business Of Law
    • Webinars
  • Hall of Fame
    • Trial Lawyer Hall of Fame

Yaz, Yasmin Among Drugs Named in Most Lawsuits in 2011

Posted on December 10, 2012 by webadmin

NewsInferno; August 17, 2012

A report issued earlier this summer revealed that together, the Yaz and Yasmin birth control pills were named in more lawsuits than almost any other medication marketed in the U.S.  That year, Yaz and Yasmin were named in more than 8,300 complaints, according to the QuarterWatch report issued by the Institute of Safe Medicine Practices in May 2012.  Only one other drug, metoclopramide (brand name Reglan), was the subject of more litigation in 2011.

Since 2011, the litigation surrounding Yaz and Yasmin has only grown.  At last count, some 12,000 lawsuits had been filed against the makers of the popular birth control pills.  Most of those are pending in a federal multidistrict litigation underway in U.S. District Court, District of Southern Illinois.  Other Yaz and Yasmin lawsuits are making their way through state courts in California, New Jersey and Pennsylvania.

Bayer, the maker of Yaz and Yasmin, revealed last month that it had already resolved more than 1,800 lawsuits for $406.2 million.  The company also said it planned to up its reserves for Yaz and Yasmin lawsuits, and will be setting aside an additional $610 million to take care of legal costs not covered by its insurance.  The cases settled so far have all alleged that Yaz and Yasmin caused young women to suffer dangerous venous blood clots.

Bayer had sought the postponement of the first trials in the federal Yaz and Yasmin litigation, and has been in settlement negotiations since late last year. Recently, the Special Master tapped to oversee the Yaz and Yasmin multidistrict litigation expressed optimism that most cases would settle within the year.

Yaz and Yasmin are both made with a synthetic form of progestin called drospirenone, which has been linked to an increased risk of blood clots, including deep vein thrombosis, or DVT.  DVT is a dangerous type of blood clot that forms deep in a vein, most often in the muscles of the leg.  A DVT has the potential to break free and travel to the lungs, becoming a potentially fatal pulmonary embolism.  Some studies have indicated that Yaz, Yasmin and other birth control pills made with the synthetic progestin, drospirenone, can increase the risks that a woman will develop DVT and other serious blood clots by as much as 75%. In April, the U.S. Food & Drug Administration (FDA) announced that the labels for Yaz, Yasmin and other drospirenone birth control pills would be updated to provide stronger information regarding their blood clot risks.

In addition to blood clots, Yaz and Yasmin lawsuits claim the drug caused a number of other serious side effects, including:

  •  Pulmonary Embolism
  • Strokes
  • Heart Attacks
  • Gallbladder problem

http://www.newsinferno.com/pharmaceuticals/yaz-yasmin-among-drugs-named-in-most-lawsuits-in-2011/40266#more-40266

Posted in Blog | Tagged Yasmin, Yaz

Comments are closed.

Recent Posts

Salmon Purchasers Reach an $85 Million Price Fixing Settlement

Salmon Purchasers Reach an $85 Million Price Fixing Settlement

May 27th, 2022

According to Reuters, who had seen the proposed settlement after it was filed on 25 May, the settlement will r[Read More...]
Ford Agrees to Pay $19 Million to Settle False Fuel Economy and Payload Claims

Ford Agrees to Pay $19 Million to Settle False Fuel Economy and Payload Claims

May 27th, 2022

Ford Motor Company as agreed to a $19.2 million multistate settlement among 40 attorneys general that concluded an investigat[Read More...]
Total Settlement in Surfside Condo Collapse Tops $1 Billion

Total Settlement in Surfside Condo Collapse Tops $1 Billion

May 25th, 2022

The proposed settlement reached nearly a year after the catastrophic Surfside building collapse along the South Flo[Read More...]
UCLA Will Pay Nearly $700 Million in Abuse Lawsuits

UCLA Will Pay Nearly $700 Million in Abuse Lawsuits

May 25th, 2022

The University of California system announced Tuesday it will pay nearly $375 million to more than 300 women who said they we[Read More...]
Things to Consider When You Sue an Insurance Provider

Things to Consider When You Sue an Insurance Provider

May 24th, 2022

We are all too acquainted with insurance coverage in our everyday lives. According to Investopedia, everyone should have[Read More...]

Contact Us | Terms of Use | Privacy Policy

Attorney information and content provided on this website is provided for the benefit of members of The National Trial Lawyers and as a public service by Legal Associations Management, Inc. The website and all data are the property of Legal Associations Management, Inc. Data, including without limitation attorney information and content, on the site may not be mined, sold, or used commercially for any purpose without the explicit written consent of Legal Associations Management, Inc. This site may not be accessed by any automated program for extracting data for any use. By accessing and using the site you agree that you will not develop, support or use software, devices, scripts, robots, or any other means or processes (including crawlers, browser plug-ins and add-ons, or any other technology) to scrape data or otherwise copy profiles and other data. Unauthorized use or attempted unauthorized use of this system may subject you to both civil and criminal penalties.